IL6 and steatosis: Increased levels of IL-6 derange liver regeneration, stimulate hepatocytes to produce various proinflammatory cytokines and potentiates necroinflammatory activity and liver injury [77,78] Postmortem biopsies of patients with COVID-19 disease showed moderate microvascular steatosis and mild lobular and portal inflammatory activity only.